Fibro-inflammatory recovery and type 2 diabetes remission following a low calorie diet but not exercise training: A secondary analysis of the DIASTOLIC randomised controlled trial.


Journal

Diabetic medicine : a journal of the British Diabetic Association
ISSN: 1464-5491
Titre abrégé: Diabet Med
Pays: England
ID NLM: 8500858

Informations de publication

Date de publication:
08 2022
Historique:
received: 11 10 2021
accepted: 08 05 2022
pubmed: 20 5 2022
medline: 22 7 2022
entrez: 19 5 2022
Statut: ppublish

Résumé

To investigate the relationship between fibro-inflammatory biomarkers and cardiovascular structure/function in people with Type 2 Diabetes (T2D) compared to healthy controls and the effect of two lifestyle interventions in T2D. Data were derived from the DIASTOLIC randomised controlled trial (RCT) and includes a comparison between those with T2D and the matched healthy volunteers recruited at baseline. Adults with T2D without cardiovascular disease (CVD) were randomized to a 12-week intervention either: (1) exercise training, (2) a low-energy (∼810 kcal/day) meal-replacement plan (MRP) or (3) standard care. Principal Component and Fisher's linear discriminant analysis were used to investigate the relationships between MRI acquired cardiovascular outcomes and fibro-inflammatory biomarkers in cases versus controls and pre- and post-intervention in T2D. At baseline, 83 people with T2D (mean age 50.5 ± 6.4; 58% male) and 36 healthy controls (mean age 48.6 ± 6.2; 53% male) were compared and 76 people with T2D completed the RCT for pre- post-analysis. Compared to healthy controls, subjects with T2D had adverse cardiovascular remodelling and a fibro-inflammatory profile (20 differentially expressed biomarkers). The 3D data visualisations showed almost complete separation between healthy controls and those with T2D, and a marked shift towards healthy controls following the MRP (15 biomarkers significantly changed) but not exercise training. Fibro-inflammatory pathways and cardiovascular structure/function are adversely altered before the onset of symptomatic CVD in middle-aged adults with T2D. The MRP improved the fibro-inflammatory profile of people with T2D towards a more healthy status. Long-term studies are required to assess whether these changes lead to continued reverse cardiac remodelling and prevent CVD.

Identifiants

pubmed: 35587779
doi: 10.1111/dme.14884
pmc: PMC9543965
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14884

Subventions

Organisme : Department of Health
ID : CDF 2014-07-045
Pays : United Kingdom

Informations de copyright

© 2022 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.

Références

Int J Med Sci. 2016 Jan 01;13(1):25-38
pubmed: 26816492
Int J Obes (Lond). 2019 Dec;43(12):2536-2544
pubmed: 30464235
Acta Diabetol. 2018 Jun;55(6):593-601
pubmed: 29546579
Front Immunol. 2019 Apr 17;10:823
pubmed: 31057548
Int J Mol Sci. 2017 Jun 21;18(6):
pubmed: 28635626
Diabetologia. 2020 May;63(5):915-923
pubmed: 32040670
Front Immunol. 2018 Jun 04;9:1236
pubmed: 29915588
Diabetes Care. 2020 Jun;43(6):1300-1310
pubmed: 32220917
Ther Adv Endocrinol Metab. 2019 Jul 05;10:2042018819861593
pubmed: 31308926
Diabetes Res Clin Pract. 2010 Mar;87(3):335-41
pubmed: 20096949
Circulation. 2009 Aug 25;120(8):699-708
pubmed: 19667236
N Engl J Med. 2018 Aug 16;379(7):633-644
pubmed: 30110583
J Am Coll Cardiol. 2013 Jul 23;62(4):263-71
pubmed: 23684677
Diabet Med. 2022 Aug;39(8):e14884
pubmed: 35587779
Circ Res. 2018 Feb 16;122(4):624-638
pubmed: 29449364
BMJ Open. 2019 Mar 30;9(3):e023207
pubmed: 30928925
Eur Cardiol. 2019 Apr;14(1):50-59
pubmed: 31131037
Lancet Diabetes Endocrinol. 2019 May;7(5):344-355
pubmed: 30852132
Diabetol Metab Syndr. 2019 Dec 30;11:113
pubmed: 31892956
Thromb Res. 2016 Apr;140:30-35
pubmed: 26896607
Diabetes. 2006 Nov;55(11):3160-5
pubmed: 17065356
Front Physiol. 2018 Apr 11;9:382
pubmed: 29695980
Diabetes Care. 2004 Mar;27(3):813-23
pubmed: 14988310
Circulation. 2019 Aug 13;140(7):e294-e324
pubmed: 31167558
Circulation. 2006 Jun 20;113(24):2851-60
pubmed: 16785351

Auteurs

Emer M Brady (EM)

Department of Cardiovascular Sciences, University of Leicester and the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, Leicester, UK.

Gaurav S Gulsin (GS)

Department of Cardiovascular Sciences, University of Leicester and the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, Leicester, UK.

Evgeny M Mirkes (EM)

School of Mathematics and Actuarial Science, University of Leicester, Leicester, UK.

Kelly Parke (K)

Department of Cardiovascular Sciences, University of Leicester and the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, Leicester, UK.

Prathap Kanagala (P)

University of Liverpool, Liverpool Centre for Cardiovascular Science, Liverpool, UK.

Leong L Ng (LL)

Department of Cardiovascular Sciences, University of Leicester and the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, Leicester, UK.

Matthew P M Graham-Brown (MPM)

Department of Cardiovascular Sciences, University of Leicester and the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, Leicester, UK.

Lavanya Athithan (L)

Department of Cardiovascular Sciences, University of Leicester and the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, Leicester, UK.

Joseph Henson (J)

Diabetes Research Centre, NIHR Leicester Biomedical Research Centre, Leicester, UK.

Emma Redman (E)

Diabetes Research Centre, NIHR Leicester Biomedical Research Centre, Leicester, UK.
University Hospitals of Leicester NHS Trust, Leicester, UK.

Jang Yang (J)

Cardiovascular & Fibrosis Translational Research, Bristol, New Jersey, USA.

Lei Zhao (L)

Cardiovascular & Fibrosis Translational Research, Bristol, New Jersey, USA.

Stavroula Argyridou (S)

Diabetes Research Centre, NIHR Leicester Biomedical Research Centre, Leicester, UK.

Laura J Gray (LJ)

Department of Health Sciences, University of Leicester, Leicester, UK.

Thomas Yates (T)

Diabetes Research Centre, NIHR Leicester Biomedical Research Centre, Leicester, UK.

Melanie J Davies (MJ)

Diabetes Research Centre, NIHR Leicester Biomedical Research Centre, Leicester, UK.
University Hospitals of Leicester NHS Trust, Leicester, UK.

Gerry P McCann (GP)

Department of Cardiovascular Sciences, University of Leicester and the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, Leicester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH